Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Yichang HEC Changjiang Pharma (1558 HK)
Watchlist
83
Analysis
Health Care
•
Hong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Nongfu Spring
•
06 Jan 2021 13:53
Full Circulation Of H-Shares: January 2021 Update
To date, 20 companies have sought approval to convert their domestic shares into H shares, 13 of which have now been given CSRC and Hong Kong...
David Blennerhassett
Follow
450 Views
Share
bullish
•
Guangzhou R&F Properties
•
17 Jul 2020 12:49
Full Circulation Of H-Shares - July Update
This update is the latest in a series dating back to Legend's Conversion of Domestic Shares in June 2018, with the most recent addition CPPCC And...
David Blennerhassett
Follow
570 Views
Share
bullish
•
ZhongAn Online P&C Insurance C
•
21 May 2020 16:47
CPPCC And Full Circulation Of H-Shares
After being delayed two months, the 2020 National People's Congress and Chinese People's Political Consultative began its annual session today,...
David Blennerhassett
Follow
318 Views
Share
bullish
•
Quantitative Analysis
•
08 May 2020 10:04
Hong Kong Buyback League Table: Evergrande, Yichang HEC, Yanzhou Coal
Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...
Ke Yan, CFA, FRM
Follow
330 Views
Share
bullish
•
Quantitative Analysis
•
20 Jan 2020 09:33
Hong Kong Buyback Weekly: Xingyi Glass, Yichang HEC, Consun Pharma
Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...
Ke Yan, CFA, FRM
Follow
330 Views
Share
First
Previous
8
9
10
11
12
13
14
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x